Panel Discussion: Evaluating the Future of Autologous & Allogeneic Therapies
Time: 11:30 am
day: Conference Day Two Pink Track
Details:
- Identify the optimal approach to maximize therapeutic efficacy
- Consider patient safety by addressing challenges related to rejection and adverse immune responses in both autologous and allogeneic therapies
- Evaluate if autologous or allogeneic therapies are best for future autoimmune therapy personalization
